LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

Search

Penumbra Inc

Suletud

SektorTervishoid

322.12 -0.75

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

321.13

Max

322.26

Põhinäitajad

By Trading Economics

Sissetulek

-176M

-130M

Müük

31M

385M

P/E

Sektori keskmine

71.985

49.8

Kasumimarginaal

-33.822

Töötajad

4,700

EBITDA

13M

68M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+9.55% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

13. mai 2026

Turustatistika

By TradingEconomics

Turukapital

-538M

13B

Eelmine avamishind

322.87

Eelmine sulgemishind

322.12

Uudiste sentiment

By Acuity

50%

50%

153 / 347 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Penumbra Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. jaan 2026, 13:29 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

15. jaan 2026, 12:35 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

15. jaan 2026, 12:29 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

6. mai 2026, 20:15 UTC

Tulu

Penumbra Not Be Providing Fincl Guidance Due to Pending Acquisition by Boston Scientific >PEN

6. mai 2026, 20:07 UTC

Tulu

Penumbra 1Q Rev $374.8M >PEN

6. mai 2026, 20:07 UTC

Tulu

Penumbra 1Q EPS 82c >PEN

25. veebr 2026, 18:02 UTC

Tulu

Penumbra: Won't Be Providing Financial Guidance for 2026, Citing Proposed Boston Scientific Deal

25. veebr 2026, 18:01 UTC

Tulu

Penumbra 4Q Rev $385.4M >PEN

25. veebr 2026, 18:01 UTC

Tulu

Penumbra 4Q Adj EPS $1.18 >PEN

25. veebr 2026, 18:01 UTC

Tulu

Penumbra 4Q EPS $1.20 >PEN

24. jaan 2026, 06:18 UTC

Omandamised, ülevõtmised, äriostud

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

15. jaan 2026, 14:37 UTC

Kuumad aktsiad

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

15. jaan 2026, 13:45 UTC

Omandamised, ülevõtmised, äriostud

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

15. jaan 2026, 12:04 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

15. jaan 2026, 12:03 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

15. jaan 2026, 12:01 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

15. jaan 2026, 12:00 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

15. jaan 2026, 12:00 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Võrdlus sarnastega

Hinnamuutus

Penumbra Inc Prognoos

Hinnasiht

By TipRanks

9.55% tõus

12 kuu keskmine prognoos

Keskmine 353 USD  9.55%

Kõrge 374 USD

Madal 335 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Penumbra Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

5 ratings

1

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

288.28 / 292.9394Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

153 / 347 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat